Skip to main content
GMRSGMR Solutions Inc.Sell5.8·$10.92
SellModerate Confidence
Investment thesis

GMR Solutions is a cheap, revenue-stable small cap (forward P/E 6.0x, price 51.0% below the $16.20 analyst target) but with weak margins, high leverage, a large recent EPS miss and heavy insider selling of 4.95% of market cap.

Thesis pillars

  • Attractive Valuation Upside→Stable
  • Large Eps Miss Thin Margins→Stable
  • Heavy Insider Selling→Stable
  • +2 more pillars — see the Why tab for full reasoning

Pillars as of Oct 24, 2026

Full reasoning →

Open full analysis

GMR Solutions Inc. (GMRS) Stock Analysis

Inst Constrain edge

SellVALUE-TRAP 2/5ValueGrowthQualityModerate Confidence

Healthcare · Medical Care Facilities

Sell if holding. Multiple concerning factors at $10.92: Leverage penalty (D/E 6.0): -1.5; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.6).

GMR Solutions Inc. operates as a provider of emergency medical services (EMS), essential alternate-site, out-of-hospital care, and mobile clinical practice groups in United States. It offers emergent medical services; non-emergent services; and other solutions, such as... Read more

$10.92+48.4% A.UpsideScore 5.8/10#14 of 35 Medical Care Facilities
QualityF-score8 / 9FCF yield—
Stop $10.16Analyst target $16.20(−13% haircut)A.R:R 3.2:1
Analyst consensus$18.63+70.6%8 analysts
$16.20Analyst target
$10.92price
$18.63mean
$30

Sell if holding. Multiple concerning factors at $10.92: Leverage penalty (D/E 6.0): -1.5; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.6). Chart setup: No clear chart pattern; technical signals are mixed. Score 5.8/10, moderate confidence.

Passes 7/9 gates (positive momentum, favorable risk/reward ratio, no SEC red flags, news events none recent, earnings proximity no date, semi cycle peak clear, materials cycle peak clear). Fails on clean insider activity. Suitability: aggressive.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-10-29

Recent Developments — GMR Solutions Inc.

Generated 2026-10-29T11:53:51Z.

Thesis

Rewards
Sector modifier (Healthcare): +0.5
Attractive valuation
Analyst upside: 48%
Risks
V7 low-quality RISK_OFF penalty: -0.5 (Q=4.6)
Leverage penalty (D/E 6.0): -1.5
Elevated risk factors

Key Metrics

P/E (TTM)—
P/E (Fwd)6.1
Mkt Cap$590M
EV/EBITDA4.9
Profit Mgn2.8%
ROE—
Rev Growth3.3%
Beta—
DividendNone
Rating analysts14

Quality Signals

Piotroski F8/9

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

3 floor-breakers·1 ceiling hit

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Support Resistance
0.9
Bollinger
1.5
52w Position
3.7

Risk profile below the gate floor. Component breakdown shows what dragged the score down.static

Debt Equity
0.0
Volatility
1.3
Days To Cover
7.2

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Quality Rank
2.9
Growth Rank
2.9
Value Rank
9.4
GatesINSIDER 4.87%=EXTREMEMomentum 5.0<5.5 (soft — BUY_NOW allowed but watch)Momentum 5.0>=4.5A.R:R 3.2 ≥ 1.5No SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY NO DATESEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Aggressive
RSI
57 · Neutral
↑ 20D MA↓ 50D MA↓ 200D MASupport $8.99Resistance $11.11

Price Targets

$10
$16
A.Upside+48.4%
A.R:R3.2:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeRisk-Off

Risk Alerts

! Insider activity: 4.87%=extreme

Earnings

We could not retrieve earnings history for GMRS.
The company may be recently listed, pre-revenue, or its beat/miss record wasn't available from our source this run. Earnings signals feed the Growth and Catalyst score dimensions — absence here doesn't affect other dimensions.

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is GMRS stock a buy right now?

Sell if holding. Multiple concerning factors at $10.92: Leverage penalty (D/E 6.0): -1.5; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.6). Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $10.16. Score 5.8/10, moderate confidence.

What is the GMRS stock price target?

Analyst target: $16.20 (+48.4% upside). Prior stop was $10.16. Stop-loss: $10.16.

What are the risks of investing in GMRS?

V7 low-quality RISK_OFF penalty: -0.5 (Q=4.6); Leverage penalty (D/E 6.0): -1.5; Elevated risk factors.

Is GMRS overvalued or undervalued?

GMR Solutions Inc. trades at a P/E of N/A (forward 6.1). TrendMatrix value score: 9.5/10. Verdict: Sell.

What do analysts say about GMRS?

14 analysts cover GMRS with a consensus score of 4.1/5. Average price target: $19.

What does GMR Solutions Inc. do?GMR Solutions Inc. operates as a provider of emergency medical services (EMS), essential alternate-site,...

GMR Solutions Inc. operates as a provider of emergency medical services (EMS), essential alternate-site, out-of-hospital care, and mobile clinical practice groups in United States. It offers emergent medical services; non-emergent services; and other solutions, such as membership programs, standby and special events, national ambulance contract with the federal emergency management agency, and other state agency and health system contracts to coordinate EMS responses. It serves health systems, large regional systems, and smaller independent hospitals, local communities, health systems, payors, public health and local, state, and federal agencies. The company was incorporated in 2015 and is headquartered in Lewisville, Texas.

Related stocks: SRTA (Strata Critical Medical, Inc.) · ASTH (Astrana Health Inc.) · AVAH (Aveanna Healthcare Holdings Inc) · STLN (Starling Oncology, Inc.) · ADUS (Addus HomeCare Corporation)
Home › Stocks › GMRS

Latest news

Latest News

Benzinga38d agoEarnings
Benzinga78d agoEarnings
Benzinga78d agoEarnings
Benzinga98d ago